MiR-125b Functions as a Tumor Suppressor and Enhances Chemosensitivity to Cisplatin in Osteosarcoma
Open Access
- 8 July 2016
- journal article
- research article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 15 (6) , NP105-NP112
Abstract
MicroRNAs are highly conserved noncoding RNA that negatively modulate protein expression at a posttranscriptional and/or translational level and are deeply involved in the pathogenesis of several types of cancers. To date, the potential microRNAs regulating the growth and progression of osteosarcoma are not fully identified yet. Previous reports have shown differentially expressed miR-125b in osteosarcoma. However, the role of miR-125b in human osteosarcoma has not been totally illuminated. In this study, we have shown that miR-125b was downregulated in human osteosarcoma tissues compared to the adjacent tissues and effects as a tumor suppressor in vitro. We found that stable overexpression of miR-125b in osteosarcoma cell lines U2OS and MG-63 inhibited cell proliferation, migration, and invasion. Our data also verified that Bcl-2 is the target of miR-125b. Meanwhile, we showed that Bcl-2 was inversely correlated with miR-125b in osteosarcoma tissues. More importantly, we proved that miR-125b increased the chemosensitivity of osteosarcoma cell lines to cisplatin by targeting Bcl-2. In conclusion, our data demonstrate that miR-125b is a tumor suppressor and support its potential application for the treatment of osteosarcoma in the future.Keywords
This publication has 30 references indexed in Scilit:
- miRNA Signatures Associate with Pathogenesis and Progression of OsteosarcomaCancer Research, 2012
- MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cellsCancer Genetics, 2012
- miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3Biochemical and Biophysical Research Communications, 2011
- Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast CancerJournal of Biological Chemistry, 2011
- Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literatureClinical & Experimental Metastasis, 2011
- Causes and consequences of microRNA dysregulation in cancerNature Reviews Genetics, 2009
- The Epidemiology of Osteosarcoma2009
- Most mammalian mRNAs are conserved targets of microRNAsGenome Research, 2008
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005